Venture Capital

Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • Chargers' Najee Harris expected to recover from fireworks accident injury, set to share rushing duties with rookie Omarion Hampton.
  • The U.S. State Department begins the largest workforce overhaul in decades, cutting domestic staff by 15% through layoffs and resignations.
20 hours
USA flag

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News
Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • Chargers' Najee Harris expected to recover from fireworks accident injury, set to share rushing duties with rookie Omarion Hampton.
  • The U.S. State Department begins the largest workforce overhaul in decades, cutting domestic staff by 15% through layoffs and resignations.
20 hours
USA flag

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from Venture Capital